健康大视野·医学分册2023,Issue(8) :38-39.DOI:10.3969/j.issn.1005-0019.2023.08.018

氯雷他定联合糠酸莫米松鼻喷雾剂治疗过敏性鼻炎的疗效评价

宋海峰
健康大视野·医学分册2023,Issue(8) :38-39.DOI:10.3969/j.issn.1005-0019.2023.08.018

氯雷他定联合糠酸莫米松鼻喷雾剂治疗过敏性鼻炎的疗效评价

宋海峰1
扫码查看

作者信息

  • 1. 广饶县人民医院,山东 东营 257300
  • 折叠

摘要

目的:氯雷他定联合糠酸莫米松鼻喷雾剂治疗过敏性鼻炎的疗效评价.方法:以我院2020年收诊的100例过敏性鼻炎患者为对象,将患者随机分为观察组和对照组,对于不同治疗药物的价值进行分析.结果:观察组与对照组患者治疗效果评分分别为0分、1分、2分、3分数据信息对比有差异,(P < 0.05).观察组与对照组患者治疗前后症状评分数据为治疗前(分)、治疗后(分)数据比较,治疗前数据没有差异(P > 0.05),治疗后数据对比有差异,(P < 0.05).观察组与对照组患者治疗后炎性因子指标IL-6、IL-10、TN

Abstract

Objective To evaluate the efficacy of loratadine combined with mometasone furoate nasal spray in the treatment of allergic rhinitis. Methods: With 100 allergic rhinitis patients admitted by our hospital in 2020, the patients were randomly divided into observation group and control group, and the value of different therapeutic drugs was analyzed. Results: The treatment effect scores of the observation and control groups were 0,1,2 and 3, respectively (P <0.05). Comparing symptom score data before and after treatment between pre-treatment (score) and post-treatment (score), there was no difference between pre-treatment data (P> 0.05) and data after treatment (P <0.05). Pre-and post-treatment IL-6, IL-10, and TNFdata were different between the observed and control groups (P <0.05). There was no difference in the adverse reaction data in the observed group (P> 0.05). Conclusion: Loratadine combined with mometasone furoate can improve the treatment effect, improve the symptom score of patients, improve the inflammatory factors, and the probability of adverse reactions is relatively low, which has promotion value.

关键词

氯雷他定/糠酸莫米松鼻喷雾剂/治疗/过敏性鼻炎/疗效评价

Key words

loratadine/Mometasone furoate nasal spray/treatment/rhinallergosis/Efficacy evaluation

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量8
段落导航相关论文